Solid Lipid Nanoparticles for Oral delivery: Formulation and In-vitro Absorption Mechanism Mansi K. Shah August 16, 2015 Drug Delivery Summit, Houston Copyrights reserved Contact: Mansi.pharma07@gmail.com

Outline Introduction Research objectives Methods, results and discussion Conclusion

Introduction BCS Class II Salt formation Particle size reduction Oral Delivery Unique physiology of GIT Formulation need for drugs having poor water solubility and high first pass metabolism BCS Class II Salt formation Particle size reduction Solid dispersion Dissolution rate enhancement High first pass metabolism??